SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Parmax Pharma

BSE: 540359 29 Sep 2025
Healthcare
₹ 33.22
Parmax Pharma Limited specializes in Pharmaceuticals within the Healthcare sector.

Parmax Pharma - Share Price & Details

Market Cap
₹14.5
High /Low
55.0 / 28.7
Stock P/E
NA
Book Value
₹-5.32
Dividend Yield
0.0
ROCE
-12.5
ROE
₹NA
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹73.6
Debt
7.70
CMP / FCF
-11.5
Debt to equity
₹84.4
NP Ann
-2.09
High price all time
81.9
Piotroski score
₹6.0
Graham Number
NA
No. Eq. Shares
0.37
Net CF
₹0.04
Net profit
-2.09
Price to book value
NA
Interest Coverage
₹-1.24
Low price all time
12.5
Industry PE
33.8
Reserves
₹-6.44
Free Cash Flow
₹-1.36

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
Parmax Pharma LimitedNANANANA14.5
DHANVANTRI JEEVAN REKHA LTD.NANANANA12.229.8
BERYL DRUGS LTD.NANANANA11.449.4

Peer Comparison Chart


About Parmax Pharma

Parmax Pharma Limited, with Security Code 540359, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Parmax Pharma Faces Significant Volatility Amid Broader Market Resilience

(16 Sep 2025)
Parmax Pharma has faced notable volatility, reaching a new 52-week low and underperforming its sector. Despite an intraday high, the stock settled lower,...
Read more →

Parmax Pharma to announce Quarterly Result

(08 Sep 2025)
Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 August 2025.
Read more →

Parmax Pharma reports standalone net loss of Rs 0.76 crore in the June 2025 quarter

(21 Aug 2025)
Net loss of Parmax Pharma reported to Rs 0.76 crore in the quarter ended June 2025 as against net profit of Rs 0.01 crore during the previous quarter ended...
Read more →

Parmax Pharma Reports Declining Sales and Profitability Challenges in August 2025 Results

(18 Aug 2025)
Parmax Pharma has reported its financial results for the quarter ending June 2025, revealing significant challenges. Net sales for the past...
Read more →

Parmax Pharma Limited (540359) Announces Strategic Shift - Unlock powerful trading tools for investors

(06 Aug 2025)
Parmax Pharma Limited (540359) Announces Strategic Shift ✌️【Stock Analysis】✌️ Our premium strategy doesn't just track price movement — it...
Read more →

What are the technical indicators suggesting about BlackRock Enhanced Global Dividend Trust - Free Daily Trading Room Entry

(06 Aug 2025)
【Stock Highlights】✌️ Expert stock recommendations based on market analysis and trends, with real-time data to help you achieve steady...
Read more →